The group B coxsackieviruses and myocarditis

Kyung Soo Kim, Günter Hufnagel, Nora M. Chapman, Steven Tracy

Research output: Contribution to journalReview article

125 Citations (Scopus)

Abstract

The six serotypes of the group B coxsackieviruses (CVB) are common human enteroviruses linked etiologically to inflammatory cardiomyopathies. This has been demonstrated by molecular detection of enteroviral RNA in human heart tissue, serologic associations with disease, and virus isolation from cases of fulminant myocarditis. The murine model of CVB-associated myocarditis has demonstrated that CVB can be attenuated through mutations at different genomic sites. Human CVB3 isolates demonstrate varying degrees of cardiovirulence in the murine model; one site of virulence determination has been mapped to domain II of the 5′ non-translated region. The interplay of CVB replication and the immune response to that replication in the heart is a complex interaction determining the extent to which the virus replication is limited and the degree to which a pathogenic inflammation of cardiac muscle occurs. Studies of CVB3-induced myocarditis in murine strains lacking subsets of the immune system or genes regulating the immune response have demonstrated a pivotal role of the T cell response to the generation of myocarditis. While CVB are associated with 20-25% of cases of myocarditis or cardiomyopathy, the severity of the disease and the existence of attenuated strains shown to generate protective immunity in animal models indicates that vaccination against the CVBs would be valuable.

Original languageEnglish (US)
Pages (from-to)355-368
Number of pages14
JournalReviews in Medical Virology
Volume11
Issue number6
DOIs
StatePublished - Dec 1 2001

Fingerprint

Human Enterovirus B
Myocarditis
Cardiomyopathies
Enterovirus
Virus Diseases
Virus Replication
Virulence
Immune System
Immunity
Myocardium
Vaccination
Animal Models
RNA
Inflammation
T-Lymphocytes
Mutation
Genes

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Kim, K. S., Hufnagel, G., Chapman, N. M., & Tracy, S. (2001). The group B coxsackieviruses and myocarditis. Reviews in Medical Virology, 11(6), 355-368. https://doi.org/10.1002/rmv.326

The group B coxsackieviruses and myocarditis. / Kim, Kyung Soo; Hufnagel, Günter; Chapman, Nora M.; Tracy, Steven.

In: Reviews in Medical Virology, Vol. 11, No. 6, 01.12.2001, p. 355-368.

Research output: Contribution to journalReview article

Kim, KS, Hufnagel, G, Chapman, NM & Tracy, S 2001, 'The group B coxsackieviruses and myocarditis', Reviews in Medical Virology, vol. 11, no. 6, pp. 355-368. https://doi.org/10.1002/rmv.326
Kim KS, Hufnagel G, Chapman NM, Tracy S. The group B coxsackieviruses and myocarditis. Reviews in Medical Virology. 2001 Dec 1;11(6):355-368. https://doi.org/10.1002/rmv.326
Kim, Kyung Soo ; Hufnagel, Günter ; Chapman, Nora M. ; Tracy, Steven. / The group B coxsackieviruses and myocarditis. In: Reviews in Medical Virology. 2001 ; Vol. 11, No. 6. pp. 355-368.
@article{c37037f2401449a4a540c3c918e7161a,
title = "The group B coxsackieviruses and myocarditis",
abstract = "The six serotypes of the group B coxsackieviruses (CVB) are common human enteroviruses linked etiologically to inflammatory cardiomyopathies. This has been demonstrated by molecular detection of enteroviral RNA in human heart tissue, serologic associations with disease, and virus isolation from cases of fulminant myocarditis. The murine model of CVB-associated myocarditis has demonstrated that CVB can be attenuated through mutations at different genomic sites. Human CVB3 isolates demonstrate varying degrees of cardiovirulence in the murine model; one site of virulence determination has been mapped to domain II of the 5′ non-translated region. The interplay of CVB replication and the immune response to that replication in the heart is a complex interaction determining the extent to which the virus replication is limited and the degree to which a pathogenic inflammation of cardiac muscle occurs. Studies of CVB3-induced myocarditis in murine strains lacking subsets of the immune system or genes regulating the immune response have demonstrated a pivotal role of the T cell response to the generation of myocarditis. While CVB are associated with 20-25{\%} of cases of myocarditis or cardiomyopathy, the severity of the disease and the existence of attenuated strains shown to generate protective immunity in animal models indicates that vaccination against the CVBs would be valuable.",
author = "Kim, {Kyung Soo} and G{\"u}nter Hufnagel and Chapman, {Nora M.} and Steven Tracy",
year = "2001",
month = "12",
day = "1",
doi = "10.1002/rmv.326",
language = "English (US)",
volume = "11",
pages = "355--368",
journal = "Reviews in Medical Virology",
issn = "1052-9276",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - The group B coxsackieviruses and myocarditis

AU - Kim, Kyung Soo

AU - Hufnagel, Günter

AU - Chapman, Nora M.

AU - Tracy, Steven

PY - 2001/12/1

Y1 - 2001/12/1

N2 - The six serotypes of the group B coxsackieviruses (CVB) are common human enteroviruses linked etiologically to inflammatory cardiomyopathies. This has been demonstrated by molecular detection of enteroviral RNA in human heart tissue, serologic associations with disease, and virus isolation from cases of fulminant myocarditis. The murine model of CVB-associated myocarditis has demonstrated that CVB can be attenuated through mutations at different genomic sites. Human CVB3 isolates demonstrate varying degrees of cardiovirulence in the murine model; one site of virulence determination has been mapped to domain II of the 5′ non-translated region. The interplay of CVB replication and the immune response to that replication in the heart is a complex interaction determining the extent to which the virus replication is limited and the degree to which a pathogenic inflammation of cardiac muscle occurs. Studies of CVB3-induced myocarditis in murine strains lacking subsets of the immune system or genes regulating the immune response have demonstrated a pivotal role of the T cell response to the generation of myocarditis. While CVB are associated with 20-25% of cases of myocarditis or cardiomyopathy, the severity of the disease and the existence of attenuated strains shown to generate protective immunity in animal models indicates that vaccination against the CVBs would be valuable.

AB - The six serotypes of the group B coxsackieviruses (CVB) are common human enteroviruses linked etiologically to inflammatory cardiomyopathies. This has been demonstrated by molecular detection of enteroviral RNA in human heart tissue, serologic associations with disease, and virus isolation from cases of fulminant myocarditis. The murine model of CVB-associated myocarditis has demonstrated that CVB can be attenuated through mutations at different genomic sites. Human CVB3 isolates demonstrate varying degrees of cardiovirulence in the murine model; one site of virulence determination has been mapped to domain II of the 5′ non-translated region. The interplay of CVB replication and the immune response to that replication in the heart is a complex interaction determining the extent to which the virus replication is limited and the degree to which a pathogenic inflammation of cardiac muscle occurs. Studies of CVB3-induced myocarditis in murine strains lacking subsets of the immune system or genes regulating the immune response have demonstrated a pivotal role of the T cell response to the generation of myocarditis. While CVB are associated with 20-25% of cases of myocarditis or cardiomyopathy, the severity of the disease and the existence of attenuated strains shown to generate protective immunity in animal models indicates that vaccination against the CVBs would be valuable.

UR - http://www.scopus.com/inward/record.url?scp=0035667319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035667319&partnerID=8YFLogxK

U2 - 10.1002/rmv.326

DO - 10.1002/rmv.326

M3 - Review article

C2 - 11746998

AN - SCOPUS:0035667319

VL - 11

SP - 355

EP - 368

JO - Reviews in Medical Virology

JF - Reviews in Medical Virology

SN - 1052-9276

IS - 6

ER -